UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in JNJ — Johnson & Johnson
CIK 861177
NEW YORK, NY
Position in JNJ
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$4,797,895,938
+$1,222,640,782 QoQ
Shares Held
19,628,113
+13.6% QoQ
Ownership
0.815%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 52.30165528392872.ToString("F0")%
Shared 0.ToString("F0")%
None 47.698344716071276.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $23,080,171,805 across 16 Drug Manufacturers - General names. JNJ ranks #2 (20.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,072,021 | $6,504,632,749 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
19,628,113 | $4,797,895,938 | |
| 3 | ABBV |
AbbVie Inc.
|
14,161,606 | $3,080,007,683 | |
| 4 | MRK |
Merck & Co., Inc.
|
20,414,819 | $2,455,698,571 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
13,199,103 | $1,839,558,979 | |
| 6 | AMGN |
Amgen Inc
|
4,784,982 | $1,683,595,911 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
22,719,320 | $1,377,926,752 | |
| 8 | PFE |
Pfizer Inc
|
34,522,932 | $969,403,925 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,797,895,938 | 19,628,113 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,575,255,156 | 17,275,937 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,948,012,784 | 15,899,109 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $3,005,229,307 | 19,674,169 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,712,274,553 | 16,354,767 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $2,233,410,907 | 15,443,306 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,686,340,909 | 16,576,212 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,632,684,776 | 18,012,348 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,092,626,532 | 13,228,564 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,216,409,550 | 14,140,676 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,729,259,694 | 11,102,791 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,855,374,584 | 11,209,368 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,737,452,040 | 11,209,368 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,950,970,468 | 11,044,271 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,706,397,784 | 10,445,628 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,859,476,884 | 10,475,336 | Shares | Other | 2022-08-12 | |
| 2022-03-31 | $1,879,238,095 | 10,603,386 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,875,851,142 | 10,965,401 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,821,492,120 | 11,278,589 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,758,818,598 | 10,676,330 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,716,023,703 | 10,441,276 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,657,287,093 | 10,530,481 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $1,493,425,698 | 10,031,070 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,505,637,090 | 10,706,372 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,503,081,946 | 11,462,533 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||